A common challenge for growth investors is identifying companies with genuine expansion potential before their share prices reflect that future. One method to address this is a combined approach, using fundamental analysis to pinpoint companies with good underlying growth metrics and layering on technical analysis to seek advantageous entry points. This strategy aims to find stocks where the business fundamentals suggest significant future earnings growth, while the price chart shows a pattern of consolidation that may come before a new upward move. The goal is to find opportunities where a company's growth story is intact, and the market is just beginning to recognize it through price action.
Harrow Inc (NASDAQ:HROW) is a pharmaceutical company that recently surfaced from a screen designed to find such opportunities. The screen filters for stocks showing good fundamental growth, acceptable financial health and profitability, and a technical pattern suggesting a possible breakout.
Fundamental Growth Assessment
The core of this strategy begins with a good growth profile, and Harrow's fundamental report highlights this as its primary strength. The company's growth rating is a strong 8 out of 10, driven by impressive historical and projected expansion.
- Past Performance: Revenue has grown by 40.99% on average annually over recent years, with a 36.41% increase in the last year alone. Earnings Per Share (EPS) surged by 104.55% over the past year.
- Future Expectations: Analysts project this momentum to continue, with EPS expected to grow by an average of 216.53% annually and revenue forecast to increase by 33.73% per year in the coming periods.
This explosive projected earnings growth is a key characteristic of a classic growth stock. While the company's profitability and financial health ratings are neutral (6 and 5, respectively), the analysis notes improving margins and a solid liquidity position. The valuation rating of 5 suggests the stock is not priced too expensively relative to its industry, especially when considering its growth prospects, as indicated by a favorable PEG ratio. For a growth investor, this combination, explosive growth metrics with reasonable valuation context and stable financials, forms an interesting fundamental picture. You can review the full details in the HROW Fundamental Analysis report.
Technical Setup for a Possible Breakout
While fundamentals define the "why," technical analysis can help with the "when." Harrow's technical rating is currently low at 2 out of 10, reflecting its position below key long-term moving averages and a negative trend over recent months. However, the strategy specifically looks for setups within such contexts, periods of consolidation that may be basing before a new trend.
The technical report notes that HROW presents a "nice setup opportunity" with a setup rating of 8 out of 10. The stock has been trading in a defined range between approximately $33 and $38 over the past month and is currently testing the upper boundary of this range.
- Key Resistance: A clear resistance zone is identified between $37.11 and $37.30, formed by a combination of trend lines.
- Consolidation Pattern: The price action shows consolidation near this resistance level, which can often come before a breakout if buying pressure increases.
- Defined Risk Level: A support zone exists below the current price around $34.06, providing a potential level for managing risk if a breakout attempt fails.
This pattern is exactly what the combined screen seeks: a stock with strong growth fundamentals that is technically positioned at a level where a move above resistance could signal the start of a new upward leg, possibly capitalizing on the fundamental growth story.
Putting the Strategy into Context
This two-part approach seeks to mitigate some of the inherent risks in growth investing. Relying only on growth metrics can lead to investing in companies whose stock prices are already overextended. Conversely, chasing technical breakouts without a fundamental foundation can result in trades based on short-lived momentum. By requiring both conditions, the strategy aims to find companies where the growth narrative is supported by financial data and the market price is exhibiting behavior that suggests accumulation and a possible readiness to advance.
For investors interested in this methodology, the specific screen that identified Harrow Inc as a candidate is designed to filter the market for similar opportunities. It continuously scans for companies showing strong growth, acceptable profitability and health, alongside constructive technical patterns.
You can find more possible candidates from this "Strong Growth Stocks with good Technical Setup Ratings" screen by viewing the full results here.
Conclusion
Harrow Inc shows the type of opportunity a combined fundamental and technical screen can find. The company's notable growth metrics, both realized and forecasted, provide the essential "growth stock" credentials. Meanwhile, its price chart shows a defined consolidation pattern at a key resistance level, offering a technical thesis for a possible entry. While its recent trend has been negative and the broader market's short-term trend is neutral, the setup suggests a scenario where positive fundamental developments could be on the verge of being reflected in the share price. As with any investment strategy, this method does not guarantee success and requires careful risk management, but it provides a structured framework for identifying stocks where the story and the chart may be aligning.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. The information presented on Harrow Inc (HROW) and the described investment strategy is based on data and reports available at the time of writing and may become outdated. Investing in stocks, particularly growth stocks, involves substantial risk of loss. You should conduct your own thorough research and due diligence and consider consulting with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.